Traws Pharma
-
Newtown-Based Traws Pharma Shares Full-Year Results, Clinical Progress
Last week, Newtown-based Traws Pharma reported its full-year 2025 financial results and provided updates on its influenza and COVID drug programs. The company, which develops…
-
Newtown’s Onconova Therapeutics Secures $14 Million and New CEO in Merger with Trawsfynydd
Newtown-based Onconova Therapeutics is joining forces in a major merger deal with drug development company, Trawsfynydd Therapeutics, writes John George for the Philadelphia Business Journal.…
Founding Partners
Advertisement
Affiliate Partners
